---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-014493"
form_type: "8-K"
ticker: "GYRE"
cik: "0001124105"
company_name: "GYRE THERAPEUTICS, INC."
filed_at: "2024-03-21T23:59:59+00:00"
generated_at: "2026-06-04T09:33:38.093403+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Gyre Therapeutics appoints Rodney Nussbaum to Board and Audit Committee

## Summary
- Rodney Nussbaum appointed Class III director effective March 20, 2024; joins Audit Committee.
- Nussbaum is a retired CPA with 40 years at Ernst & Young, KPMG, and Arthur Andersen.
- Currently Managing Executive of Atago Advisory, LLC, an accounting advisory firm.
- Compensation per non-employee director policy; enters standard indemnification agreement.

## SEC filing metadata
- accession: 0001140361-24-014493
- form_type: 8-K
- ticker: GYRE
- cik: 0001124105
- company_name: GYRE THERAPEUTICS, INC.
- filed_at: 2024-03-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1124105/000114036124014493/0001140361-24-014493-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1124105/000114036124014493/ef20024709_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-014493
- JSON: https://secwatch.observer/filing/0001140361-24-014493.json
- Plain text: https://secwatch.observer/filing/0001140361-24-014493.txt

## Key facts
- Executive change
  Rodney Nussbaum was appointed as Director at GYRE THERAPEUTICS, INC..
  - Action: appointed
  - Role: Director
  source text: appointed Rodney Nussbaum as a Class III director to serve until the Company’s 2024 Annual Meeting of Stockholders and until his successor is duly elected and qualified.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1124105/000114036124014493/0001140361-24-014493-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.